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1. Introduction {#efs25169-sec-0002}
===============

Article 3 of the Regulation (EC) No 1332/2008[1](#efs25169-note-1006){ref-type="fn"} provides definition for 'food enzyme' and 'food enzyme preparation'. "'Food enzyme' means a product obtained from plants, animals or micro‐organisms or products thereof including a product obtained by a fermentation process using micro‐organisms: (i) containing one or more enzymes capable of catalysing a specific biochemical reaction; and (ii) added to food for a technological purpose at any stage of the manufacturing, processing, preparation, treatment, packaging, transport or storage of foods.'Food enzyme preparation' means a formulation consisting of one or more food enzymes in which substances such as food additives and/or other food ingredients are incorporated to facilitate their storage, sale, standardisation, dilution or dissolution."

Before January 2009, food enzymes other than those used as food additives were not regulated or were regulated as processing aids under the legislation of the Member States. On 20 January 2009, Regulation (EC) No 1332/2008 on food enzymes came into force. This Regulation applies to enzymes that are added to food to perform a technological function in the manufacture, processing, preparation, treatment, packaging, transport or storage of such food, including enzymes used as processing aids. Regulation (EC) No 1331/2008 established the European Union (EU) procedures for the safety assessment and the authorisation procedure of food additives, food enzymes and food flavourings. The use of a food enzyme shall be authorised only if it is demonstrated that: it does not pose a safety concern to the health of the consumer at the level of use proposed,there is a reasonable technological need, andits use does not mislead the consumer.

All food enzymes currently on the EU market and intended to remain on that market, as well as all new food enzymes, shall be subjected to a safety evaluation by the European Food Safety Authority (EFSA) and approval via an EU Community list.

The 'Guidance on submission of a dossier on a food enzyme for evaluation' (EFSA, [2009a](#efs25169-bib-0008){ref-type="ref"}) lays down the administrative, technical and toxicological data required.

1.1. Background and Terms of Reference as provided by the requestor {#efs25169-sec-0003}
-------------------------------------------------------------------

### 1.1.1. Background as provided by the European Commission {#efs25169-sec-0004}

Only food enzymes included in the Union list may be placed on the market as such and used in foods, in accordance with the specifications and conditions of use provided for in Article 7(2) of Regulation (EC) No 1332/2008[1](#efs25169-note-1006){ref-type="fn"} on food enzymes.

Five applications have been introduced by the companies "Danisco US Inc." for the authorisation of the food enzyme Hexose oxidase from a genetically modified strain of *Hansenula polymorpha* (strain DP‐Jza21); "Novozymes A/S." for the authorisation of the food enzyme Pectin lyase from a genetically modified strain of *Aspergillus niger* (strain NZYM‐PN); "Puratos NV" for the authorisation of the food enzyme Xylanase from a genetically modified strain of *Bacillus subtilis* (strain LMG S‐27588); the Association of Manufacturers and Formulators of Enzyme Products (AMFEP) for the authorisation of the food enzyme Beta‐galactosidase from *Kluyveromyces lactis* and "AB Enzymes GmbH" for the authorisation of the food enzyme Lysophospholipase from a genetically modified strain of Trichoderma reesei (strain RF7206).

Following the requirements of Article 12.1 of Commission Regulation (EU) No 234/2011[2](#efs25169-note-1007){ref-type="fn"} implementing Regulation (EC) No 1331/2008[3](#efs25169-note-1008){ref-type="fn"}, the Commission has verified that the five applications fall within the scope of the food enzyme Regulation and contain all the elements required under Chapter II of that Regulation.

### 1.1.2. Terms of Reference {#efs25169-sec-0005}

The European Commission requests the European Food Safety Authority to carry out the safety assessments of the food enzymes Hexose oxidase from a genetically modified strain of *Hansenula polymorpha* (strain DP‐Jza21), Pectin lyase from a genetically modified strain of *Aspergillus niger* (strain NZYM‐PN), Xylanase from a genetically modified strain of *Bacillus subtilis* (strain LMG S‐27588), Beta‐galactosidase from *Kluyveromyces lactis* and Lysophospholipase from a genetically modified strain of Trichoderma reesei (strain RF7206), in accordance with the article 17.3 of Regulation (EC) No 1332/2008 on food enzymes.

1.2. Interpretation of the Terms of Reference {#efs25169-sec-0006}
---------------------------------------------

The present scientific opinion addresses the European Commission request to carry out the safety assessment of food enzyme xylanase from *Bacillus subtilis* strain LMG S‐27588 submitted by Puratos N. V.

1.3. Information on existing authorisations and evaluations {#efs25169-sec-0007}
-----------------------------------------------------------

The applicant only reports either authorised food enzymes other than xylanase produced by the same production organism, *B. subtilis*, or authorised xylanase from production organisms other than *B. subtilis*.

2. Data and methodologies {#efs25169-sec-0008}
=========================

2.1. Data {#efs25169-sec-0009}
---------

The applicant submitted a dossier in support of the application for authorisation of the food enzyme xylanase produced from genetically modified *B. subtilis* (strain LMG S‐27588). The food enzyme is intended to be used in baking processes.

2.2. Methodologies {#efs25169-sec-0010}
------------------

The assessment was conducted in line with the principles described in the EFSA Guidance on transparency in the scientific aspects of risk assessment (EFSA, [2009b](#efs25169-bib-0009){ref-type="ref"}) and following the relevant Guidances from the EFSA Scientific Committee.

The current guidance on the submission of a dossier for safety evaluation of a food enzyme (EFSA, [2009a](#efs25169-bib-0008){ref-type="ref"}) has been followed by the CEF Panel for the evaluation of the application with the exception of the exposure assessment, which was carried out in accordance to the methodology described in the CEF Panel statement on the exposure assessment of food enzymes (EFSA CEF Panel, [2016](#efs25169-bib-0012){ref-type="ref"}).

3. Assessment {#efs25169-sec-0011}
=============

3.1. Technical data {#efs25169-sec-0012}
-------------------

### 3.1.1. Identity of the food enzyme {#efs25169-sec-0013}

IUBMB nomenclature: Endo‐1,4‐β‐xylanase

Systematic name: 4‐β‐D‐Xylan xylanohydrolase

Synonyms: Xylanase; endo‐1,4‐[d]{.smallcaps}‐β‐xylanase

IUBMB No: EC 3.2.1.8

CAS No: 9025‐57‐4

EINECS No: 232‐800‐2.

### 3.1.2. Chemical parameters {#efs25169-sec-0014}

The endo‐1,4‐β‐xylanase produced from the genetically modified *B. subtilis* strain LMG S‐27588 consists of a ■■■■■, including a signal peptide of ■■■■■, which is cleaved off during secretion of the enzyme protein. The molecular mass of the mature protein of ■■■■■ was calculated based on the amino acid sequence. The protein homogeneity status of the food enzyme was investigated by sodium dodecyl sulfate‐polyacrylamide gel electrophoresis (SDS‐PAGE) analysis. The apparent molecular mass based on the SDS‐PAGE pattern is about ■■■■■. The gels presented showed one main protein band and some minor protein bands of higher molecular mass. The food enzyme did not show protease activity and very low alpha‐amylase activity. No other enzymatic activities have been reported by the applicant.

Data on the chemical parameters of the food enzyme were provided for six food enzyme batches, three batches to be used for commercialisation and three batches used for the toxicological tests (Table [1](#efs25169-tbl-0001){ref-type="table"}). The average total organic solids (TOS) of the three food enzyme batches for commercialisation was 4.03%; the values ranged from 2.66% to 5.13%.

The enzyme activity/mg TOS ratios of the three food enzyme batches for commercialisation ranged from 13.6 to 40.9 Xylanase Units (ADXU)/mg TOS (Table [1](#efs25169-tbl-0001){ref-type="table"}). The average value of 27.6 ADXU/mg TOS was used for subsequent calculations.

###### 

Compositional data of the food enzyme

                                                                                                                             Batch                                 
  ------------------------------------------------------------------- ------------------------------------------------------ ------- ------- ------ ------ ------- -------
  Endo‐1,4‐β‐xylanase activity                                        ADXU/mL batch[d](#efs25169-note-0010){ref-type="fn"}   1,211   1,089   696    224    3,264   1,216
  Protein                                                             \%                                                     1.4     0.9     1.5    NA     15.2    NA
  Ash                                                                 \%                                                     0.6     0.5     0.6    0.5    5.4     1.8
  Water                                                               \%                                                     95.1    96.8    94.3   97.0   57.0    93.4
  Total organic solids (TOS)[e](#efs25169-note-0011){ref-type="fn"}   \%                                                     4.3     2.7     5.1    2.4    37.6    4.8
  Activity/mg TOS                                                     ADXU/mg TOS                                            28.2    40.9    13.6   9.2    8.7     25.3

NA: not analysed.

Batch used for the *in vitro* micronucleus test.

Batch used for the repeated dose 90‐day oral toxicity study.

Batch used for the bacterial reverse mutation test.

ADXU: Xylanase Units (see Section [3.1.3](#efs25169-sec-0015){ref-type="sec"}).

TOS calculated as 100% -- % water -- % ash.

John Wiley & Sons, Ltd

The lead content on the three commercial batches and the batches used for toxicological studies was below 0.5 mg/kg which complies with the specification for lead (≤ 5 mg/kg) as laid down in the general specifications and considerations for enzymes used in food processing (FAO/WHO, [2006](#efs25169-bib-0016){ref-type="ref"}). No antimicrobial activity was detected in any of these batches (FAO/WHO [2006](#efs25169-bib-0016){ref-type="ref"}).

The food enzyme complies with the microbiological criteria as laid down in the general specifications and considerations for enzymes used in food processing (FAO/WHO, [2006](#efs25169-bib-0016){ref-type="ref"}), which stipulate that *Escherichia coli* and *Salmonella* species are absent in 25 g of sample and total coliforms should not exceed 30 colony forming units (CFU) per gram.

The applicant has provided information on the identity of the antifoam agent used and the method for analysis. Taking into account the nature and properties of the antifoam agent, the manufacturing process and the quality assurance system implemented by the applicant, the Panel considers its use as of no safety concern.

The compositional data provided for the food enzyme batches are considered sufficient.

### 3.1.3. Properties of the food enzyme {#efs25169-sec-0015}

The food enzyme catalyses the hydrolysis of endo‐1,4‐β‐[d]{.smallcaps}‐xylosidic linkages in xylan (including arabinoxylan, which is xylan branched with arabinose) resulting in the generation of (1→4)‐β‐[d]{.smallcaps}‐xylan oligosaccharides of different lengths (1,4‐β‐xylan; 1,4‐β‐arabinoxylan). This xylanase does not require co‐factors.

The enzymatic activity is determined based on the hydrolysis of beechwood xylan and is expressed in Xylanase Units/mL (ADXU/mL). The analytical principle is based on hydrolysis of the xylan to reducing carbohydrates (reaction conditions: pH = 6, T = 70°C, incubation time = 15 min). One ADXU is defined as the amount of enzyme that produces 1 μm of product (measured in xylose equivalents) per minute and per ml from xylan under the assay conditions.

The food enzyme has been characterised regarding its temperature and pH profiles. The xylanase showed maximum activity in the assay at 100°C, the highest temperature tested, and was active within a pH range of 5--9 (with an optimum of pH 6--7). The enzyme activity decreases gradually upon treatments at temperatures above 90°C. Approximately 30% enzyme activity remains after 4 h of thermal treatment at 100°C. This indicates the food enzyme is thermostable.

### 3.1.4. Information on the microbial source material {#efs25169-sec-0016}

#### 3.1.4.1. Information relating to the genetically modified microorganism {#efs25169-sec-0017}

The endo‐1,4‐β‐xylanase production strain *B. subtilis* LMG S‐27588 ■■■■■ is deposited in the LMG -- Culture Collection, a node of the Belgian Co‐ordinated Collection of Microorganisms located at the University of Gent, under deposit code LMG S‐27588.

#### 3.1.4.2. Characteristics of the parental and recipient microorganisms {#efs25169-sec-0018}

The parental microorganism is the bacterium *B. subtilis* ■■■■■

■■■■■

■■■■■

■■■■■

■■■■■

#### 3.1.4.3. Characteristics of the donor microorganisms {#efs25169-sec-0019}

■■■■■

■■■■■

■■■■■

#### 3.1.4.4. Description of the genetic modification process {#efs25169-sec-0020}

The production strain *B. subtilis* LMG S‐27588 was developed from the recipient strain ■■■■■

■■■■■

#### 3.1.4.5. Safety aspects of the genetic modification {#efs25169-sec-0021}

■■■■■

■■■■■

■■■■■

■■■■■

■■■■■

■■■■■

### 3.1.5. Manufacturing process {#efs25169-sec-0022}

The food enzyme is manufactured according to the Food Hygiene Regulation (EC) No 852/2004[4](#efs25169-note-1009){ref-type="fn"} and in accordance with current Good Manufacturing Practice (GMP). A dataset related to the manufacturing process including a list of raw materials used and a production flow process from fermentation and downstream processes was provided.

The food enzyme is produced by a pure culture in a contained, submerged, fermentation system with conventional process controls in place.

After completion of the fermentation, the solid biomass is removed from the fermentation broth by filtration. The filtrate containing the enzyme is then further purified and concentrated by ultrafiltration. The production strain could not be detected in three different batches of the food enzyme. From each batch, before formulation, a ■■■■■

Recombinant DNA was detected in three enzyme batches, tested in triplicate, by polymerase chain reaction (PCR) amplifying a fragment of about ■■■■■ of the xylanase coding sequence.

The Panel considered the information provided on the manufacturing process as sufficient.

### 3.1.6. Safety for the environment {#efs25169-sec-0023}

The production strain could not be detected in the food enzyme (see Section [3.1.5](#efs25169-sec-0022){ref-type="sec"}). However, recombinant DNA was demonstrated to be present in all batches tested. The applicant provided laboratory transformation tests with samples from production batches which were negative and argued that presence of recombinant DNA was therefore not a concern. However, the CEF Panel did not consider these laboratory‐based data as relevant for the risk assessment.

On the other hand, no sequences that cause safety concern (such as AMR marker genes or genes encoding known toxins) have been introduced in the production strain, therefore the Panel is of the opinion that the recombinant DNA present in the food enzyme does not pose a risk to the environment.

### 3.1.7. Case of need and intended conditions of use {#efs25169-sec-0024}

As proposed by the applicant, the food enzyme is intended for use in baking processes at an intended use level of up to 800 ADXU/kg flour, corresponding to 29 mg TOS/kg flour.

The food enzyme is added to the raw materials during the preparation of the dough. It is used to hydrolyse (arabino) xylans, which interact with gluten and water, thus contributing to reduce the viscosity of the dough. The decrease in dough viscosity facilitates the handling of the dough, resulting in more uniform products with slightly increased volume and an improved crumb structure.

### 3.1.8. Reaction and fate in food {#efs25169-sec-0025}

The xylanase catalyses the hydrolysis of 1,4‐β‐[d]{.smallcaps}‐xylosidic linkages in xylan resulting in the production of (1→4)‐β‐[d]{.smallcaps}‐xylan and (1→4)‐β‐[d]{.smallcaps}‐arabinoxylan oligosaccharides of different lengths. Xylanase is specific in its action, not known to catalyse other reactions than this endo‐hydrolysis of xylans to shorter xylans chains, xylooligosaccharides and xylose. These reaction products are naturally present in xylan‐containing foods. Based on the substrate specificity of the xylanase, no unintended reaction products are expected in foods.

The data and information provided indicate that the xylanase is largely inactivated during baking processes under the intended use conditions.

3.2. Dietary exposure {#efs25169-sec-0026}
---------------------

Exposure estimates were calculated using the methodology described in the CEF Panel statement on the exposure assessment of food enzymes (EFSA CEF Panel et al., [2016](#efs25169-bib-0012){ref-type="ref"}). The assessment of the food processes covered in this opinion involved selection of relevant food groups and application of process and technical conversion factors (Appendix [B](#efs25169-sec-0002){ref-type="sec"}). These input data were subject to a stakeholder consultation through open calls,[5](#efs25169-note-1010){ref-type="fn"} and adjusted in accordance with feedback received.

### 3.2.1. EFSA Comprehensive European Food Consumption Database {#efs25169-sec-0027}

Since 2010, the EFSA Comprehensive European Food Consumption Database (hereafter the EFSA Comprehensive Database[6](#efs25169-note-1011){ref-type="fn"}) has been populated with detailed national data on food consumption. Competent authorities in European countries provide EFSA with data regarding the level of food consumption by individual consumers, as taken from the most recent national dietary survey in their country (EFSA, [2011a](#efs25169-bib-0010){ref-type="ref"}).

The food consumption data gathered by EFSA were collected using different methodologies and thus direct country‐to‐country comparisons should be made with caution. Depending on the food category and the level of detail used in exposure calculations, uncertainties might be introduced owing to subjects possibly underreporting and/or misreporting of consumption amounts. Nevertheless, the EFSA Comprehensive Database is the best available source of food consumption data across Europe.

Food consumption data from the following population groups: infants, toddlers, children, adolescents, adults and the elderly were used for the exposure assessment. For the present assessment, food consumption data were available from 33 different dietary surveys carried out in 19 European countries (Appendix [A](#efs25169-sec-1001){ref-type="sec"}).

Consumption records were codified according to the FoodEx classification system (EFSA, [2011b](#efs25169-bib-0011){ref-type="ref"}).

### 3.2.2. Exposure assessment methodology {#efs25169-sec-0028}

Chronic exposure was calculated based on individual consumption, averaged over the total survey period, excluding surveys with only one day per subject. High‐level exposure/intake was calculated for only those population groups in which the sample size was sufficiently large to allow calculation of the 95th percentile (EFSA, [2011a](#efs25169-bib-0010){ref-type="ref"}).

The exposure per FoodEx category was subsequently added to derive an individual total exposure per day. Finally, these exposure estimates were averaged over the number of survey days and normalised for individual body weight (bw), resulting in an individual average exposure/day per kg bw for the survey period. This was done for all individuals in the survey and per age class, resulting in distributions of individual average exposure per survey and age class. Based on these distributions, the mean and 95th percentile exposures were calculated per survey for the total population and per age class.

### 3.2.3. Exposure to food enzyme--TOS according to the intended use proposed by the applicant {#efs25169-sec-0029}

Exposure to the food enzyme--TOS was based on intended use and the recommended maximum use levels of the food enzyme--TOS provided by the applicant (Section [3.1.8](#efs25169-sec-0025){ref-type="sec"}). Food enzyme--TOS exposure was calculated from foods produced involving a baking process.

Relevant food groups and/or individual foods were selected from the Comprehensive Database and were assumed to always contain the food enzyme--TOS at the maximum recommended use level. This will result in an overestimation of exposure to food enzyme--TOS.

To facilitate matching of the reported use levels for baking processes with foods identified in the Comprehensive Database, the selected foods were disaggregated to ingredient level as appropriate, and converted into the corresponding raw material, i.e. flour, via the application of conversion factors (Appendix [B](#efs25169-sec-1002){ref-type="sec"}). For example, consumption of 100 g of bread was converted into an intake of 70 g flour (recipe fraction of 0.7) and then multiplied by 29 mg TOS/kg flour, as provided by the applicant, to arrive at an exposure of 2.03 mg TOS/100 g bread.

Exposure to the food enzyme--TOS was calculated by multiplying values reported for each food category by their respective consumption amount per kilogram of body weight (kg bw) separately for each individual in the database. Table [2](#efs25169-tbl-0002){ref-type="table"} provides an overview of the derived exposure estimates. The average and 95th percentile exposure to the food enzyme‐TOS per age class, country and survey are reported in Appendix [C](#efs25169-sec-1003){ref-type="sec"} -- Table C.1. The contribution of the food enzyme--TOS from each FoodEx category to the total dietary exposure is indicated in Appendix [C](#efs25169-sec-1003){ref-type="sec"} -- Table C.2.

###### 

Summary of estimated dietary exposure to food enzyme--TOS in six population groups

  Population group                               Estimated exposure (mg/kg bw per day)                                                                                   
  ---------------------------------------------- --------------------------------------- ------------------- ------------------- ------------------- ------------------- -------------------
  Age range                                      3--11 months                            12--35 months       3--9 years          10--17 years        18--64 years        ≥ 65 years
  Min--max mean (number of surveys)              0.020--0.088 (6)                        0.076--0.183 (10)   0.080--0.173 (18)   0.047--0.115 (17)   0.034--0.070 (17)   0.033--0.061 (14)
  Min--max 95th percentile (number of surveys)   0.118--0.249 (5)                        0.172--0.309 (7)    0.149--0.325 (18)   0.085--0.228 (17)   0.067--0.138 (17)   0.062--0.110 (14)

bw: body weight.

John Wiley & Sons, Ltd

### 3.2.4. Uncertainty analysis {#efs25169-sec-0030}

In accordance with the guidance provided in the EFSA opinion related to uncertainties in dietary exposure assessment (EFSA, [2007](#efs25169-bib-0007){ref-type="ref"}), the following sources of uncertainties have been considered and are summarised in Table [3](#efs25169-tbl-0003){ref-type="table"}.

###### 

Qualitative evaluation of the influence of uncertainties on the dietary exposure estimate

  Sources of uncertainties                                                                                                                                                         Direction of impact
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------
  **Model input data**                                                                                                                                                             
  Consumption data: different methodologies/representativeness/underreporting/misreporting/no portion size standard                                                                +/--
  Use of data from food consumption survey of a few days to estimate long‐term (chronic) exposure for high percentiles (95th percentile)                                           \+
  Possible national differences in categorisation and classification of food                                                                                                       +/--
  **Model assumptions and factors**                                                                                                                                                
  FoodEx categories included in the exposure assessment were assumed to always contain the food enzyme--TOS                                                                        \+
  Exposure to food enzyme--TOS was always calculated based on the recommended maximum use level                                                                                    \+
  Selection of broad FoodEx categories for the exposure assessment based on the description of the food process provided by the applicant (based on examples given by applicant)   \+
  Use of recipe fractions in disaggregation FoodEx categories likely to contain the food enzyme                                                                                    +/--
  Use of technical factors in the exposure model                                                                                                                                   +/--

TOS: total organic solid.

+: uncertainty with potential to cause overestimation of exposure; --: uncertainty with potential to cause underestimation of exposure.

John Wiley & Sons, Ltd

The conservative approach applied to the exposure estimate to food enzyme--TOS, in particular, assumptions made on the occurrence and use levels of this specific food enzyme, is likely to have led to a considerable overestimation of the exposure.

3.3. Toxicological data {#efs25169-sec-0031}
-----------------------

Batches 4--6 (Table [1](#efs25169-tbl-0001){ref-type="table"}) were used for the toxicological assays (batch 4 used for the *in vitro* micronucleus test; batch 5 for the repeated dose 90‐day oral toxicity study; batch 6 for the bacterial reverse mutation test). They were obtained by the same steps (microfiltration, ultrafiltration, sterile filtration) as applied to the commercial batches, except for an additional concentration step via freeze‐drying for batch 5. Batches 4 and 5 have the lowest specific activity (enzyme activity/mg TOS), which indicates that they are cruder than the three batches for commercialisation and their use for toxicological testing is considered suitable.

### 3.3.1. Genotoxicity {#efs25169-sec-0032}

#### 3.3.1.1. Bacterial Reverse Mutation Test {#efs25169-sec-0033}

In order to investigate the potential of the food enzyme endo‐1,4‐β‐xylanase to induce gene mutations in bacteria, an Ames test was performed according to OECD Test Guideline 471 (OECD, [1997](#efs25169-bib-0022){ref-type="ref"}) and following Good Laboratory Practice (GLP) in five strains of *Salmonella* Typhimurium (TA98, TA100, TA1535, TA1537 and TA102), in the presence or absence of metabolic activation. Two experiments were carried out applying the plate incorporation assay (first experiment) and the pre‐incubation method (second experiment) using five different concentrations: 312.5, 625, 1,250, 2,500 and 5,000 μg food enzyme/plate, corresponding to 15, 30, 60, 120 and 240 μg TOS/plate. Appropriate positive control chemicals and water for injection (as vehicle control) were evaluated concurrently. All positive control chemicals induced significant increases in revertant colony numbers, confirming the sensitivity of the tests and the efficacy of the S9‐mix, while negative controls were within the historical control ranges. No precipitate was observed at any tested concentration in any tester strain with or without S9‐mix. No significant toxicity, as evident by the absence or reduction in the mean number of revertant colonies and absence or reduction in the background bacterial lawn, was observed in any strain or test condition used.

No significant increase in the mean number of revertant colonies was observed at any tested concentration in any tester strains with or without S9‐mix. Exceptions were strains TA1537 and TA98 in the absence of metabolic activation, where increases in the number of revertants were observed at the highest doses. However, these effects were not reproducible and were not considered to be biologically relevant. Therefore, the Panel concluded that the food enzyme did not induce gene mutations in the bacterial reverse mutation assay under the test conditions employed for this study.

#### 3.3.1.2. *In vitro* micronucleus test {#efs25169-sec-0034}

The *in vitro* micronucleus assay was carried out according to the OECD Test Guideline 487 (OECD, [2010](#efs25169-bib-0024){ref-type="ref"}) and following GLP. Duplicate cultures of whole blood were treated with culture medium (vehicle control), the food enzyme or appropriate positive controls. Two experiments were performed applying a short treatment (4 + 20 hours recovery) in the presence and absence of S9‐mix, and a continuous treatment (20 + 28 hours recovery) without S9‐mix. Three concentrations of the food enzyme per experimental condition were selected for the analysis of micronuclei (MN) (i) 1,250, 2,500 and 5,000 μg food enzyme/mL, corresponding to 50.38, 100.75 and 201.5 μg TOS/mL (short treatment); (ii) 3,000, 4,000 and 5,000 μg food enzyme/mL corresponding to ca. 71, 234 and 355 μg TOS/mL (continuous treatment). Two thousand cells were scored per concentration. The positive controls induced statistically significant increases in the frequency of micronucleated binucleated cells (MNBN), demonstrating the sensitivity of the test system and the efficacy of the S9‐mix. No significant cytotoxicity was observed after treatments both in the presence and absence of S9‐mix. No statistically significant increase in the frequency of MNBN was observed at any concentration and treatment condition. The Panel concluded that the food enzyme endo‐1,4‐β‐xylanase did not induce an increase in the frequency of cells containing micronuclei in cultured human lymphocytes under the test conditions employed for this study.

### 3.3.2. Repeated dose 90‐day oral toxicity study in rodents {#efs25169-sec-0035}

A repeated dose 90‐day oral toxicity study in rodents was performed in accordance with OECD Test Guideline 408 (OECD, [1998](#efs25169-bib-0023){ref-type="ref"}) and following GLP. Groups of 10 male and 10 female Sprague--Dawley rats received the food enzyme (batch 5) at the dose levels of 1,920, 2,880 and 3,840 ADXU/kg bw per day, corresponding to 221, 332 and 443 mg TOS/kg bw per day (referred as low, mid and high dose, respectively) by oral gavage during a 13 week period. The control group received the same amount of water (1.17 mL/kg bw per day) by gavage as given to the highest dose group with food enzyme.

There were no premature deaths or unscheduled sacrifices during the study, apart from a single male given low dose, sacrificed prematurely in week 13 after blood sampling. During the 13‐week treatment period, hypersalivation was observed in some test item‐treated groups in both sexes. These observations were considered as test item treatment related but were considered as non‐adverse. No treatment‐related changes in the Functional Observation Battery tests, mean body weight, food intake, ophthalmology, organ weight, macroscopic and microscopic pathology were observed. In haematology decreases in mean cell haemoglobin and mean cell haemoglobin concentration were observed in high dose females. Blood biochemistry investigations showed a statistically significant increase in alkaline phosphatase activity in high--dose males and females. There was a statistically significant increase of cholesterol in mid and high--dose females. These changes were attributed to the test item treatment but were considered of limited toxicological significance as they were without any microscopic correlates.

Overall, the Panel derived a NOAEL at the high dose level of 443 mg TOS/kg bw per day for both males and females.

A comparison of the NOAEL (443 mg TOS/kg bw per day) from the 90‐day study with the highest estimated dietary exposure, calculated to be up to 0.325 mg TOS/kg bw per day, resulted in a margin of exposure (MOE) of 1,363, indicating that there is no concern.

3.4. Allergenicity {#efs25169-sec-0036}
------------------

The allergenicity assessment considers only the food enzyme and not any carrier or other excipient which may be used in the final formulation.

The allergenicity of endo‐1,4‐β‐xylanase produced from the genetically modified *B. subtilis* strain LMG S‐27588 has been assessed by comparison of its amino acid sequence with those of known allergens, according to the EFSA Scientific opinion on the assessment of allergenicity of GM plants and microorganisms and derived food and feed of the Scientific Panel on Genetically Modified Organisms (EFSA GMO Panel, [2010](#efs25169-bib-0014){ref-type="ref"}). Using higher than 35% identity in a sliding window of 80 amino acids as criterion, no match was found.

Several cases of respiratory allergy following occupational inhalation of aerosols containing xylanase (Elms et al., [2003](#efs25169-bib-0015){ref-type="ref"}) or other enzymes have been reported (Martel et al., [2010](#efs25169-bib-0019){ref-type="ref"}). However, several studies have shown that adults with occupational asthma to an enzyme (such as α‐amylase) can commonly ingest the corresponding allergen without acquiring clinical symptoms of food allergy (Cullinan et al., [1997](#efs25169-bib-0006){ref-type="ref"}; Brisman, [2002](#efs25169-bib-0005){ref-type="ref"}; Poulsen, [2004](#efs25169-bib-0025){ref-type="ref"}; Armentia et al., [2009](#efs25169-bib-0001){ref-type="ref"}). However, only incidental cases have been described where ingestion of α‐amylase led to adverse reaction in patients sensitised through the respiratory route (Baur and Czuppon, [1995](#efs25169-bib-0003){ref-type="ref"}; Kanny and Moneret‐Vautrin, [1995](#efs25169-bib-0017){ref-type="ref"}; Moreno‐Ancillo et al., [2004](#efs25169-bib-0020){ref-type="ref"}). Such information is not reported for xylanase. Therefore, it can be concluded that the likelihood of an allergic reaction upon oral ingestion of xylanase produced from the genetically modified *B. subtilis* strain LMG S‐27588, in individuals respiratory sensitised to xylanase cannot be excluded, but is considered to be low. In addition, no information is available on oral sensitisation or elicitation reactions of this xylanase. The potential cross reactivity of food enzymes was studied by Bindslev‐Jensen et al. ([2006](#efs25169-bib-0004){ref-type="ref"}) There were no indications of cross reactivity between 19 different commercial food enzymes and the main allergens represented by 400 patients (allergic to inhalation allergens, food allergens, allergens of bee or wasp or drugs) included in this study.

Taken together, the Panel considers that there are no indications for allergic reactions by dietary exposure to the food enzyme endo‐1,4‐β‐xylanase produced from the genetically modified *B. subtilis* strain LMG S‐27588.

Conclusions {#efs25169-sec-0037}
===========

Based on the genetic modifications, the manufacturing process, the compositional and biochemical data, the dietary exposure, the findings in the toxicological studies and allergenicity assessment, the Panel concluded that the food enzyme endo‐1,4‐β‐xylanase produced from *B. subtilis* strain LMG S‐27588 by the company Puratos N. V. does not give rise to safety concerns under the intended conditions of use.

The Panel noted that recombinant DNA was demonstrated to be present in all batches of the food enzyme tested.

Remark {#efs25169-sec-0038}
======

The carrier of the commercial enzyme preparation is food grade ■■■■■. As ■■■■■ contains substances and products causing allergies (respiratory and food allergies) and intolerances (gluten intolerance) (Regulation (EU) No 1169/2011)^8^, the food enzyme preparation might contain ■■■■■ allergens and gluten, which may give rise to safety concerns in ■■■■■‐allergic and gluten‐intolerant consumers.

Documentation provided to EFSA {#efs25169-sec-0039}
==============================

Dossier "Application for authorisation of endo‐1.4‐β‐xylanase from a genetically modified strain of *Bacillus subtilis* LMG S‐27588 in accordance with Regulation (EC) No 1331/2008", June 2015. Submitted by Puratos N. V.Additional information was received from Puratos in August 2017.

Abbreviations {#efs25169-sec-0040}
=============

ADXUXylanase UnitsAMFEPAssociation of Manufacturers and Formulators of Enzyme ProductAMRAntimicrobial resistanceBwbody weightCASChemical Abstracts ServiceCEFEFSA Panel on Food Contact Material, Enzymes, Flavourings and Processing AidsCFUcolony forming unitsFAOFood and Agricultural OrganisationGLPGood Laboratory PracticeGMGenetically ModifiedGMOGenetically Modified OrganismsGMPGood Manufacturing PracticeIUBMBInternational Union of Biochemistry and Molecular BiologyLMGLaboratory of Microbiology, university of GentMOEMargin of exposureMNmicronucleiMNBNmicronucleated binucleated (cells)NOAELno observed adverse effect levelOECDOrganisation for Economic Cooperation and DevelopmentPCRpolymerase chain reactionrRNAribosomal ribonucleic acidSDS‐PAGESodium dodecyl sulfate‐poly acrylamide gel electrophoresisTOStotal organic solidsWHOWorld Health Organization

Appendix A -- Population groups considered for the exposure assessment {#efs25169-sec-1001}
======================================================================

 {#efs25169-sec-0041}

PopulationAge rangeCountries with food consumption surveys covering more than one dayInfantsFrom 12 weeks on up to and including 11 months of ageBulgaria, Denmark, Finland, Germany, Italy, United KingdomToddlersFrom 12 months up to and including 35 months of ageBelgium, Bulgaria, Denmark, Finland, Germany, Italy, Netherlands, Spain, United KingdomChildren[a](#efs25169-note-1012){ref-type="fn"}From 36 months up to and including 9 years of ageAustria, Belgium, Bulgaria, Czech Republic, Denmark, Finland, France, Germany, Greece, Italy, Latvia, Netherlands, Spain, Sweden, United KingdomAdolescentsFrom 10 years up to and including 17 years of ageAustria, Belgium, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Italy, Latvia, Spain, Sweden, United KingdomAdultsFrom 18 years up to and including 64 years of ageAustria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Hungary, Ireland, Italy, Latvia, Netherlands, Romania, Spain, Sweden, United KingdomThe elderly[a](#efs25169-note-1012){ref-type="fn"}From 65 years of age and olderAustria, Belgium, Denmark, Finland, France, Germany, Hungary, Ireland, Italy, Romania, Sweden, United Kingdom[^1]

Appendix B -- FoodEx categories used to derive exposure estimates for the food enzyme--TOS and the respective conversion factors {#efs25169-sec-1002}
================================================================================================================================

 {#efs25169-sec-0042}

FoodEx codeFoodEx categoryConversion factor from FoodEx food group to raw material[a](#efs25169-note-1014){ref-type="fn"}Recipe fraction[b](#efs25169-note-1015){ref-type="fn"}mg TOS/kg flourA.01Grains and grain‐based products (unspecified)0.8129A.01.03Grain milling products (unspecified)1129A.01.03.001Wheat milling products (unspecified)1129A.01.03.001.001Wheat flour, brown1129A.01.03.001.002Wheat flour, Durum1129A.01.03.001.003Wheat flour, white1129A.01.03.001.004Wheat flour, wholemeal1129A.01.03.001.005Graham flour1129A.01.03.001.006Wheat flour, gluten free1129A.01.03.001.014Wheat starch1.2129A.01.03.002Rye milling products (unspecified)1129A.01.03.002.001Rye flour, gluten free1129A.01.03.002.002Rye flour, light1129A.01.03.002.003Rye flour, medium1129A.01.03.002.004Rye flour, wholemeal1129A.01.03.003Buckwheat milling products (unspecified)1129A.01.03.003.001Buckwheat flour1129A.01.03.004Corn milling products (unspecified)1129A.01.03.004.001Corn flour1129A.01.03.004.003Corn starch1.3129A.01.03.005Oat milling products (unspecified)1129A.01.03.005.002Oat flour1129A.01.03.005.004Oat starch1.2129A.01.03.006Rice milling products (unspecified)1129A.01.03.006.001Rice flour1129A.01.03.006.002Rice flour white1129A.01.03.006.003Rice flour, instant1129A.01.03.006.004Rice starch1.2129A.01.03.007Spelt milling products1129A.01.03.008Other milling products (unspecified)1129A.01.03.008.001Amaranth flour1129A.01.03.008.002Barley flour1129A.01.03.008.003Chapatti flour1129A.01.03.008.004Flour mix, wheat/rye/barley/oats1129A.01.03.008.005Millet flour1129A.01.03.008.007Sorghum flour1129A.01.04Bread and rolls (unspecified)10.729A.01.04.001Wheat bread and rolls10.729A.01.04.002Rye bread and rolls10.729A.01.04.003Mixed wheat and rye bread and rolls10.729A.01.04.004Multigrain bread and rolls10.729A.01.04.005Unleavened bread, crisp bread and rusk (unspecified)10.829A.01.04.005.001Crisp bread, rye wholemeal10.929A.01.04.005.002Crisp bread, rye, light10.929A.01.04.005.003Crisp bread, wheat, wholemeal10.929A.01.04.005.004Crisp bread, wheat, light10.929A.01.04.005.005Rusk, light10.929A.01.04.005.006Rusk, wholemeal10.929A.01.04.005.007Pita bread10.729A.01.04.005.008Matzo10.929A.01.04.005.009Tortilla10.729A.01.04.006Other bread10.729A.01.04.007Bread products10.729A.01.07Fine bakery wares (unspecified)10.529A.01.07.001Pastries and cakes (unspecified)10.529A.01.07.001.001Beignets10.1529A.01.07.001.002Buns10.729A.01.07.001.003Cake from batter10.2529A.01.07.001.004Cheese cream cake10.2429A.01.07.001.005Cheese cream sponge cake10.2429A.01.07.001.006Chocolate cake10.2429A.01.07.001.007Chocolate cake with fruits10.2429A.01.07.001.008Cream cake10.2429A.01.07.001.009Cream cheese cake10.2429A.01.07.001.010Cream custard cake10.2429A.01.07.001.011Cream custard sponge cake10.2429A.01.07.001.012Croissant10.529A.01.07.001.013Croissant, filled with chocolate10.529A.01.07.001.014Croissant, filled with cream10.529A.01.07.001.015Croissant, filled with jam10.529A.01.07.001.016Croquembouche10.1529A.01.07.001.017Doughnuts10.2429A.01.07.001.018Clair10.1529A.01.07.001.019Flan10.529A.01.07.001.020Fruit cake10.629A.01.07.001.021Fruit pie10.1529A.01.07.001.022Cheese pie10.1529A.01.07.001.023Fruit tart10.1529A.01.07.001.024Gingerbread10.629A.01.07.001.025Gougere10.1529A.01.07.001.026Kringles10.2529A.01.07.001.027Nut cream cake10.2429A.01.07.001.028Pancakes10.2529A.01.07.001.029Profiterole10.1529A.01.07.001.030Pyramid cake10.2529A.01.07.001.031Rhubarb flan10.1529A.01.07.001.032Scone10.529A.01.07.001.033Sponge dough10.2529A.01.07.001.034Sponge cake10.2529A.01.07.001.035Sponge cake roll10.2529A.01.07.001.036Muffins10.2529A.01.07.001.037Waffles10.2529A.01.07.001.038Apple strudel10.1529A.01.07.001.039Cream‐cheese strudel10.2429A.01.07.001.040Cheese pastry goods from puff pastry10.1529A.01.07.001.041Croissant from puff pastry10.629A.01.07.001.042Brioche10.529A.01.07.001.044Lebkuchen10.629A.01.07.001.045Dumpling10.529A.01.07.001.046Cake marbled, with chocolate10.529A.01.07.001.047Marzipan pie10.2529A.01.07.001.048Baklava10.1529A.01.07.002Biscuits (cookies)10.929A.01.07.002.001Biscuits, sweet, plain10.929A.01.07.002.002Biscuits, chocolate filling10.8129A.01.07.002.003Biscuits, cream filling10.8129A.01.07.002.004Biscuits, fruit filling10.8129A.01.07.002.005Biscuits, vanilla filling10.8129A.01.07.002.006Butter biscuits10.8129A.01.07.002.007Biscuit, iced10.8129A.01.07.002.008Speculaas10.929A.01.07.002.009Biscuits, sweet, wheat wholemeal10.929A.01.07.002.010Biscuits, oat meal10.929A.01.07.002.011Biscuits, spelt meal10.929A.01.07.002.012Biscuits, salty10.929A.01.07.002.013Biscuits, salty, with cheese10.8129A.01.07.002.014Sticks, salty10.8129A.17.03.003Biscuits, rusks and cookies for children10.929A.18.04.001Find bakery products for diabetics10.529A.19.01.001Sandwich and sandwich‐like meal10.3229A.19.01.002Pizza and pizza‐like pies10.329[^2][^3][^4]

Appendix C -- Dietary exposure estimates to the food enzyme‐TOS in details {#efs25169-sec-1003}
==========================================================================

 {#efs25169-sec-0043}

Information provided in this appendix is shown in an excel file (downloadable <http://onlinelibrary.wiley.com/wol1/doi/10.2903/j.efsa.2018.5169/suppinfo>).

The file contains two sheets, corresponding to two tables.

Table C.1: Average and 95th percentile exposure to the food enzyme‐TOS per age class, country and survey.

Table C.2: The contribution of the food enzyme--TOS from each FoodEx category to the total dietary exposure.

Supporting information
======================

###### 

Dietary exposure estimates to the food enzyme--TOS in details

###### 

Click here for additional data file.

Regulation (EC) No 1332/2008 of the European Parliament and of the Council of 16 December 2008 on Food Enzymes and Amending Council Directive 83/417/EEC, Council Regulation (EC) No 1493/1999, Directive 2000/13/EC, Council Directive 2001/112/EC and Regulation (EC) No 258/97. OJ L 354, 31.12.2008, p. 7--15.

Commission Regulation (EU) No 234/2011 of 10 March 2011 implementing Regulation (EC) No 1331/2008 of the European Parliament and of the Council establishing a common authorisation procedure for food additives, food enzymes and food flavourings. OJ L 64, 11.3.2011, p. 15--24.

Regulation (EC) No 1331/2008 of the European Parliament and of the Council of 16 December 2008 establishing a common authorisation procedure for food additives, food enzymes and food flavourings. OJ L 354, 31.12.2008, p. 1--6.

Regulation (EC) No 852/2004 of the European Parliament and of the Council of 29 April 2004 on the hygiene of food additives. OJ L 226, 25.6.2004, p. 3--21.

<http://www.efsa.europa.eu/en/data/call/161110>

<http://www.efsa.europa.eu/en/food-consumption/comprehensive-database>

[^1]: The terms 'children' and 'the elderly' correspond, respectively, to 'other children' and the merge of 'elderly' and 'very elderly' in the Guidance of EFSA on the 'Use of the EFSA Comprehensive European Food Consumption Database in Exposure Assessment' (EFSA, [2011a](#efs25169-bib-0010){ref-type="ref"}).

[^2]: TOS: total organic solids.

[^3]: Available at see <http://www.fao.org/fileadmin/templates/ess/documents/methodology/tcf.pdf>

[^4]: Derived from publically available recipe information, and/or food label information (such as Mintel\'s Global New Products Database <http://www.mintel.com/global-new-products-database>).
